Your browser doesn't support javascript.
loading
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
Sirois, Isabelle; Isabelle, Maxim; Duquette, Jérôme D; Saab, Frederic; Caron, Etienne.
Afiliação
  • Sirois I; CHU Sainte-Justine Research Center; isabelle.sirois.hsj@ssss.gouv.qc.ca.
  • Isabelle M; CHU Sainte-Justine Research Center.
  • Duquette JD; CHU Sainte-Justine Research Center.
  • Saab F; CHU Sainte-Justine Research Center.
  • Caron E; CHU Sainte-Justine Research Center; Department of Pathology and Cellular Biology, Faculty of Medicine, Université de Montréal; etienne.caron@umontreal.ca.
J Vis Exp ; (176)2021 10 15.
Article em En | MEDLINE | ID: mdl-34723952
Immunopeptidomics is an emerging field that fuels and guides the development of vaccines and immunotherapies. More specifically, it refers to the science of investigating the composition of peptides presented by major histocompatibility complex (MHC) class I and class II molecules using mass spectrometry (MS) technology platforms. Among all the steps in an MS-based immunopeptidomics workflow, sample preparation is critically important for capturing high-quality data of therapeutic relevance. Here, step-by-step instructions are described to isolate MHC class I and II-associated peptides by immunoaffinity purification from quality control samples, from mouse (EL4 and A20), and human (JY) cell lines more specifically. The various reagents and specific antibodies are thoroughly described to isolate MHC-associated peptides from these cell lines, including the steps to verify the beads-binding efficiency of the antibody and the elution efficiency of the MHC-peptide complexes from the beads. The protocol can be used to establish and standardize an immunopeptidomics workflow, as well as to benchmark new protocols. Moreover, the protocol represents a great starting point for any non-experts in addition to foster the intra- and inter-laboratory reproducibility of the sample preparation procedure in immunopeptidomics.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Antígenos de Histocompatibilidade Classe I Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: J Vis Exp Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Antígenos de Histocompatibilidade Classe I Tipo de estudo: Guideline / Risk_factors_studies Limite: Humans Idioma: En Revista: J Vis Exp Ano de publicação: 2021 Tipo de documento: Article